Frequency of COVID-19 vaccine side effects and its associated factors among the vaccinated population of Pakistan: A cross-sectional study

被引:7
|
作者
Yasmin, Farah [1 ]
Najeeb, Hala [1 ]
Siddiqui, Hasan Fareed [1 ]
Asghar, Muhammad Sohaib [2 ]
Awan, Hashir Ali [1 ]
Usama, Rana Muhammad [3 ]
Allahuddin, Zoha [1 ]
Tahir, Muhammad Junaid [4 ]
Ullah, Kaleem [5 ]
Eljack, Mohammed Mahmmoud Fadelallah [6 ]
机构
[1] Dow Univ Hlth Sci, Dow Med Coll, Dept Med, Karachi, Pakistan
[2] Dow Univ Hlth Sci, Dow Univ Hosp, Dept Med, Ojha Campus, Karachi, Pakistan
[3] Lahore Gen Hosp, Dept Med, Lahore, Pakistan
[4] Pakistan Kidney & Liver Inst & Res Ctr PKLI & RC, Dept Radiol, Lahore, Pakistan
[5] Pir Abdul Qadir Shah Jelani Inst Med Sci, Dept Surg, Liver Transplant & Hepatobiliary Unit, Gambat, Pakistan
[6] Univ Bakht Alruda, Fac Med & Hlth Sci, Dept Community Med, Ad Duwaym, Sudan
关键词
adverse effects; COVID-19; vaccine; postvaccination symptoms; SARS-CoV-2; vaccine side effects;
D O I
10.1002/hsr2.1071
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Coronavirus disease 2019 (COVID-19) vaccine side effects have an important role in the hesitancy of the general population toward vaccine administration. Therefore, this study was conducted to document the COVID-19 vaccine side effects in our population. Materials and Methods: An online survey-based, cross-sectional study was carried out from September 1, 2021, to October 1, 2021, to document the side effects of the COVID-19 vaccine among the general public. The questionnaire included participants' sociodemographic data, type of vaccine, comorbidities, previous COVID-19 infection, and assessment of side effects reported by them. Results: The majority of the participants were <20 years of age (62.2%), females (74.9%), belonged to the educational sector (58.1%), residents of Sindh (65.7%), and were previously unaffected by COVID-19 infection (73.3%). Sinovac (38.7%) followed by Sinopharm (30.4%) and Moderna (18.4%) were administered more frequently. Commonly reported side effects were injection site pain (82%), myalgia (55%), headache (46%), fatigue/malaise (45%), and fever (41%). Vaccine side effects were more likely to be reported with the first dose as compared to the second dose. On regression analysis, factors associated with occurrence of side effects included younger age (odds ratio [OR]: 6.000 [2.065-17.431], p < 0.001), female gender (OR: 2.373 [1.146-4.914], p = 0.020), marital status (OR: 0.217 [0.085-0.556], p < 0.001), graduate level of education (OR: 0.353 [0.153-0.816], p = 0.015), and occupation being either retired, freelancers, or social workers (OR: 0.310 [0.106-0.909]), p = 0.033). Previous infection with COVID-19 (p = 0.458) and comorbidities were found unrelated (p = 0.707) to the occurrence of side effects. Conclusion: The overall prevalence of local side effects was quite higher than the systemic ones. Further large-scale studies on vaccine safety are required to strengthen public confidence in the vaccination drive.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Prevalence and associated factors of COVID-19 among Moroccan physicians: A cross-sectional study
    El Baldi, Marwa
    Laghrissi, Amina
    Marso, Zakia
    Chellat, Fatima Zahra
    Berraho, Mohamed
    Tachfouti, Nabil
    El Fakir, Samira
    Mellas, Soufiane
    Fahd, Amar Mohamed
    Kohen, Jamal
    Boulaguige, Fouad
    Naamane, Jamal
    Lahmadi, Khalid
    El Rhazi, Karima
    PLOS ONE, 2022, 17 (11):
  • [32] Factors Associated with COVID-19 Vaccine Hesitancy in Uganda: A Population-Based Cross-Sectional Survey
    Kabagenyi, Allen
    Wasswa, Ronald
    Nannyonga, Betty K.
    Nyachwo, Evelyne B.
    Kagirita, Atek
    Nabirye, Juliet
    Atuhaire, Leonard
    Waiswa, Peter
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 6837 - 6847
  • [33] Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study
    Omeish, Haya
    Najadat, Angam
    Al-Azzam, Sayer
    Tarabin, Nada
    Abu Hameed, Amer
    Al-Gallab, Neebal
    Abbas, Hadeel
    Rababah, Lana
    Rabadi, Majd
    Karasneh, Reema
    Aldeyab, Mamoon A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [34] Prevalence and factors associated with belief in COVID-19 vaccine efficacy in Indonesia: A cross-sectional study
    Effendi, Diyan Ermawan
    Laksono, Agung Dwi
    Pranata, Setia
    Nantabah, Zainul Khaqiqi
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (07) : 308 - 313
  • [35] Prevalence and factors associated with belief in COVID-19 vaccine efficacy in Indonesia: A cross-sectional study
    Diyan Ermawan Effendi
    Agung Dwi Laksono
    Setia Pranata
    Zainul Khaqiqi Nantabah
    Asian Pacific Journal of Tropical Medicine, 2022, (07) : 308 - 313
  • [36] Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study
    Mohsin, Md
    Mahmud, Sultan
    Mian, Ashraf Uddin
    Hasan, Prottay
    Muyeed, Abdul
    Ali, Md. Taif
    Ahmed, Fee Faysal
    Islam, Ariful
    Rahman, Maisha Maliha
    Islam, Mahfuza
    Khan, Md Hasinur Rahaman
    Rahman, M. Shafiqur
    VACCINE: X, 2022, 12
  • [37] Willingness to receive COVID-19 vaccine and associated factors among teachers in Dambi Dollo, Ethiopia: a cross-sectional study
    Shiferaw, Desalegn
    Melaku, Chara
    Assefa, Lemessa
    Kinati, Tadele
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [38] Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study
    Abay, Eleleta Surafel
    Belew, Mezmur Dawit
    Ketsela, Beza Seleshi
    Mengistu, Enderas Eneyew
    Getachew, Liya Sisay
    Teferi, Yonas Ademe
    Zerihun, Abebe Bekele
    PLOS ONE, 2022, 17 (06):
  • [39] Severity of COVID-19 Disease in Vaccinated and Non Vaccinated COVID-19 Positive Cases: A Cross-sectional Study
    Sagi, Padma Sravani
    Kumar, A. Venkata Kalyan
    Bhanu, Sahila
    Keerthi, C.
    Neeraja, D.
    Rao, R. Srinivas
    Durga, T.
    Prasad, B. R. Shyam
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (02) : IC1 - IC3
  • [40] Prevalence and factors associated with COVID-19 vaccine hesitancy among adults in Ghana: a population-based cross-sectional study in the Volta Region
    Frempong, Clinton Sekyere
    Tarkang, Elvis Enowbeyang
    Amu, Hubert
    Gborglah, Miriam
    Salu, Samuel
    Otoo, David Mensah
    DISCOVER PUBLIC HEALTH, 2024, 21 (01)